FierceBiotech

F2G raises $100M to fund 2nd attempt to get new antifungal class to market

After F2G’s first attempt to get a brand-new class of antifungal to market was derailed by the FDA, the U.K.-based biotech has secured $100 million in fresh funding to bankroll another push towards ...
IGN

Goodyear F2G Super Corsair

The Goodyear F2G Super Corsair is a Tier 8 fighter plane available for the U.S.A. The F2G Super Corsair is required in order to unlock the Vought F6U Pirate. Every ...
Yahoo

Antifungal drug developer F2G raises $100 million to fight 'superbugs', fund late-stage trial

(Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for ...
FierceBiotech

Shionogi splashes $100M on F2G's rare fungal disease drug to unlock new class of medicine

Shionogi is betting $100 million upfront on a new class of antifungal medicine, teaming up with F2G to land the Asian and European rights to a late-phase drug candidate that could help ...
KHON2

F2G Receives Complete Response Letter from FDA for New Drug Application for Olorofim for The Treatment of Invasive Fungal Infections; Plans Resubmission With Additional Data ...

F2G remains committed to bringing olorofim to patients and intends to meet with FDA in the coming months to align on next steps to obtain approval using the full data set from pivotal clinical Study ...
BioWorld

F2G receives a CRL and a request for more data for its antifungal

BioWorld - Sunday, February 16, 2025 See today's BioWorld Home » F2G receives a CRL and a request for more data for its antifungal To read the full article sign up for free or sign in.